Skip to main content
Journal of Cancer Research and Clinical Oncology logoLink to Journal of Cancer Research and Clinical Oncology
. 1990 May;116(3):251–258. doi: 10.1007/BF01612899

Expression of key enzymes of purine and pyrimidine metabolism in a hepatocyte-derived cell line at different phases of the growth cycle

Doris Mayer 1,2,, Yutaka Natsumeda 1, Tadashi Ikegami 1, Mary Faderan 1, May Lui 1, Jahangir Emrani 1, Melissa Reardon 1, Edith Oláh 1, George Weber 1
PMCID: PMC12200564  PMID: 2370250

Abstract

The effect of growth phase on enzymatic activities of the de novo and salvage pathways for purine and pyrimidine nucleotide synthesis was studied in a hepatocyte-derived cell line from the rat. The cells were in lag phase after plating for 36 h; log phase started at 48 h and persisted up to 120 h of culture. Then the cells stopped growing and entered into plateau phase (144 h). In non-proliferating cells (144 h of culture) the basal activities of the enzymes of purine de novo biosynthesis were 1.7- to 6.8-fold higher than in normal rat liver, those of pyrimidine de novo synthesis showed 0.6- to 30-fold increase in activity. The purine salvage enzymes were unchanged, and the pyrimidine salvage enzymes were 3.1- to 7.4-fold higher compared to normal liver. During the growth cycle all enzymes except the purine salvage enzymes, which did not change, showed a peak in activity at 72 h of culture (log phase). The increase in activity in log phase compared to plateau phase was 1.3- to 2.4-fold for purine de novo synthetic enzymes, 1.1- to 2.4-fold for pyrimidine de novo enzymes, and 1.4- to 4.7-fold for pyrimidine salvage enzymes. The specific activities of the enzymes in exponentially growing cells were comparable either to that in 24-h regenerating liver, or to that in hepatomas of low or medium growth rate. It was concluded that the enzymatic pattern and metabolic state of the cells shared some features with regenerating liver, others with tumors, although they were not tumorigenic after transplantation into athymic nude mice.

Key words: Purine and pyrimidine metabolism, Enzyme expression, Growth phase, Liver cell line

References

  1. Aoki T, Morris HP, Weber G (1982) Regulatory properties and behavior of activity of carbamoyl-phosphate synthetase II (glutamine-hydrolyzing) in normal and proliferating tissues. J Biol Chem 257:432–438 [PubMed] [Google Scholar]
  2. Boritzki TJ, Jackson RC, Morris HP, Weber G (1981) Guanosine 5′-phosphate synthetase and guanosine 5′-phosphate kinase in rat hepatomas and kidney tumors. Biochim Biophys Acta 658:102–110 [DOI] [PubMed] [Google Scholar]
  3. Denis C, Mayer D, Trocheris V, Viallard V, Paris H, Murat JC (1985) Study of carbohydrate metabolism in glycogen-storing cell lines derived from cultured rat hepatocytes. Int J Biochem 17:247–251 [DOI] [PubMed] [Google Scholar]
  4. Elliot WL, Weber G (1984) Proliferation-linked increase in phosphoribosyl-formylglycinamidine synthetase acticity (EC 6.3.5.3). Cancer Res 44:2430–2434 [PubMed] [Google Scholar]
  5. Harkrader RJ, Jackson RC, Ross DA, Weber G (1980) Increase in liver and kidney deoxycytidine kinase activity linked to neoplastic transformation. Biochem Biophys Res Commun 96:1633–1639 [DOI] [PubMed] [Google Scholar]
  6. Ikegami T, Natsumeda Y, Weber G (1985) A direct assay for inosine 5' monophosphate dehydrogenase (EC 1.2.1.14) activity. Anal Biochem 150:155–160 [DOI] [PubMed] [Google Scholar]
  7. Kizaki H, Williams JC, Morris HP, Weber G (1980) Increased cytidine 5′-triphosphate synthetase activity in rat and human tumors. Cancer Res 40:3921–3927 [PubMed] [Google Scholar]
  8. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ (1951) Protein measurement with the Folin phenol reagent. J Biol Chem 193:265–275 [PubMed] [Google Scholar]
  9. Mayer D (1988) Regulation of carbohydrate metabolism in a glycogen-storing liver cell line. In: Roberfroid MB, Préat V (eds) Experimental hepatocarcinogenesis. Plenum, New York, pp 283–296 [Google Scholar]
  10. Mayer D, Schäfer B (1982) Biochemical and morphological characterization of glycogen-storing epithelial liver cell lines. Exp Cell Res 138:1–14 [DOI] [PubMed] [Google Scholar]
  11. Mayer D, Klimek F, Hacker HJ, Seelmann-Eggebert G, Bannasch P (1989) Carbohydrate metabolism in hepatic pre-neoplasia. In: Bannasch P, Keppler D, Weber G (eds) Liver cell carcinoma. Kluwer, Dordrecht, pp 329–345 [Google Scholar]
  12. Natsumeda Y, Prajda N, Donohue JP, Glover JL, Weber G (1984) Enzymic capacities of purine de novo and salvage pathways for nucleotide synthesis in normal and neoplastic tissues. Cancer Res 44:2475–2479 [PubMed] [Google Scholar]
  13. Ogawa H, Shiraki H, Natsuda Y, Kakiuchi K, Nakagawa H (1977) Purification, crystallization and properties of adenylosuccinate synthetase from rat skeletal muscle. J Biochem (Tokyo) 81:859–869 [DOI] [PubMed] [Google Scholar]
  14. Oláh E, Lui MS, Tzeng DY, Weber G (1980) Phase and cell cycle specificity of pyrazofurin action. Cancer Res 40:2869–2875 [PubMed] [Google Scholar]
  15. Prajda N, Katanuma N, Morris HP, Weber G (1975) Imbalance of purine metabolism in hepatomas of different growth rates as expressed in behavior of glutamine-phosphoribosylpyrophosphate amidotransferase (amidophosphoribosyl-transferase, EC 2.4.2.14). Cancer Res 35:3061–3068 [PubMed] [Google Scholar]
  16. Takeda E, Weber G (1981) Role of ribonucleotide reductase in expression of the neoplastic program. Life Sci 8:1007–1014 [DOI] [PubMed] [Google Scholar]
  17. Weber G (1983) Biochemical strategy of cancer cells and the design of chemotherapy; G.H.A. Clowes Memorial Lecture. Cancer Res 43:3466–3492 [PubMed] [Google Scholar]
  18. Weber G (1989) Biochemical strategy of hepatocellular carcinoma. In: Bannasch P, Keppler D, Weber G (eds) Liver cell carcinoma. Kluwer, Dordrecht, pp 361–374 [Google Scholar]
  19. Weber G, Oláh E, Lui MS, Kizaki H, Tzeng DY, Takeda E (1980) Biochemical commitment to replication in cancer cells. Adv Enzyme Regul 18:3–26 [DOI] [PubMed] [Google Scholar]
  20. Weber G, Oláh E, Denton JE, Lui MS, Takeda E, Tzeng DY, Ban J (1981) Dynamics of modulation of biochemical programs in cancer cells. Adv. Enzyme Regul 19:87–102 [DOI] [PubMed] [Google Scholar]
  21. Zhen Y-S, Lui MS, Weber G (1983) Effects of acivicin and dipyridamole on hepatoma 3924A cells. Cancer Res 43:1616–1619 [PubMed] [Google Scholar]

Articles from Journal of Cancer Research and Clinical Oncology are provided here courtesy of Springer

RESOURCES